Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial.

Slides:

Advertisements

Similar presentations

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD

Advertisements

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease Ramon Berguer, MD, PhD, Mark D. Morasch,

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

Richard M. Green, MD, William M

Tibiotibial vein bypass grafts: A new operation for limb salvage

Result of bypass grafting for upper limb ischemia

Enrico Ascer, MD, Frank J. Veith, MD, Sushil K. Gupta, MD

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D.

Pedal bypass versus tibial bypass with autogenous vein: A comparison of outcome and hemodynamic results Joseph R. Schneider, MD, PhD, Daniel B. Walsh,

Nontraumatic mesenteric vascular emergencies

Impact of a critical pathway on postoperative length of stay and outcomes after infrainguinal bypass Andrew C. Stanley, MD, Maryann Barry, RN, Thayer.

Jeffrey P. Carpenter, MD, John E. Tomaszewski, MD

Surgical treatment of venous obstruction and insufficiency

Axillofemoral bypass: A tool with a limited role

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting? Richard.

Return to well-being and function after infrainguinal revascularization Gary W. Gibbons, MD, Anne M. Burgess, RN, Edward Guadagnoli, PhD, Frank B. Pomposelli,

Axillopopliteal bypass for limb salvage

Edmond J. Prendiville, MB, FRCSI, Anson Yeager, MD, Thomas F

Early complications and long-term outcome after open surgical treatment of popliteal artery aneurysms: Is exclusion with saphenous vein bypass still the.

Walter J. McCarthy, MD, William H. Pearce, MD, William R

Lateral approach to the popliteal artery

Potential predictors of outcome in patients with tissue loss who undergo infrainguinal vein bypass grafting James M. Seeger, MD, Henry A. Pretus, MD,

Walter J. McCarthy, MD, Charles L. Mesh, MD, William D

Dorsalis pedis arterial bypass: Durable limb salvage for foot ischemia in patients with diabetes mellitus Frank B. Pomposelli, MD, Edward J. Marcaccio,

A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting Desiree H.C. Burger, MDa, A.Pieter.

Interruption of critical aortoiliac collateral circulation during nonvascular operations: A cause of acute limb-threatening ischemia Alan M. Dietzek,

First textbook in vascular surgery

Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease Norman R.

A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical.

Infrainguinal arterial reconstruction for claudication: Is it worth the risk? An analysis of 409 procedures John Byrne, MD, R.Clement Darling III, MD,

Factors affecting the patency of infrainguinal bypass

Long-term outcome after early infrainguinal graft failure

Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial

Prospective, randomized comparison of ringed and nonringed polytetrafluoroethylene femoropopliteal bypass grafts: A preliminary report Sushil K. Gupta,

Antonio V. Sterpetti, M. D. , Richard D. Schultz, M. D. , Richard J

Kurt R. Wengerter, MD, Frank J. Veith, MD, Sushil K

Philip S. K. Paty, MD, Dhiraj M. Shah, MD, Javid Saifi, MD, Benjamin B

The consequences of a failed femoropopliteal bypass grafting: Comparison of saphenous vein and PTFE grafts Mark R. Jackson, MDa, Todd P. Belott, MDa,

Long-term assessment of cryopreserved vein bypass grafting success

Mesenteric venous thrombosis

Anthony D. Whittemore, MD, Magruder C. Donaldson, MD, John A

Ankle and foot fasciotomy: An adjunctive technique to optimize limb salvage after revascularization for acute ischemia Enrico Ascer, MD, Berish Strauch,

Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts C.J. Buckley, MD, S. Abernathy,

Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: The failure of low-density seeding to improve patency Malcolm Herring, MD,

Composite sequential bypasses to the ankle and beyond for limb salvage

Joseph G. Magnant, MD, Jack L. Cronenwett, MD, Daniel B

Popliteal artery aneurysms

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

Peripheral vascular bypass in juvenile-onset diabetes mellitus: Are aggressive revascularization attempts justified? Christopher J. Kwolek, MD, Frank.

Surgical treatment of threatened reversed infrainguinal vein grafts

Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial Charles McCollum, MB, ChB, MD, FRCS, Christine Alexander, Dip N, Glenda Kenchington,

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

Surgical management of severe acute lower extremity ischemia

Isolated profundaplasty for limb salvage

Stanley Ziomek, M. D. , William J. Quiñones-Baldrich, M. D. , Ronald W

Early experience with cryopreserved saphenous vein allografts as a conduit for complex limb-salvage procedures Philip J. Walker, FRACS, R.Scott Mitchell,

A metropolitan experience with infrainguinal revascularization

Peter G. Kalman, M. D. , Marilyn Hosang, R. N. , Claudio Cina, M. D

Homologous veins as an arterial substitute: Long-term results

Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study J.N. Albertini, MD, X. Barral, MD,

Determinants of successful peroneal artery bypass

Gary A. Tannenbaum, MD, Frank B. Pomposelli, MD, Edward J

Benjamin B. Chang, MD, R. Clement Darling, MD, Devon E. M

Endovascular-assisted versus conventional in situ saphenous vein bypass grafting: Cumulative patency, limb salvage, and cost results in a 39-month multicenter.

Lessons learned in adopting the in situ saphenous vein bypass

Superficial femoral artery eversion endarterectomy: A useful adjunct for infrainguinal bypass in the presence of limited autogenous vein Spence M. Taylor,

Presentation transcript:

Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions Frank J. Veith, M.D., Sushil K. Gupta, M.D., Enrico Ascer, M.D., Sheila White-Flores, B.S.N., Russell H. Samson, M.D., Larry A. Scher, M.D., Jonathan B. Towne, M.D., Victor M. Bernhard, M.D., Patricia Bonier, R.N., William R. Flinn, M.D., Patricia Astelford, R.N., James S.T. Yao, M.D., Ph.D., John J. Bergan, M.D. Journal of Vascular Surgery Volume 3, Issue 1, Pages 104-114 (January 1986) DOI: 10.1016/0741-5214(86)90073-X Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 1 Cumulative life-table primary patency rates for all randomized bypasses performed to popliteal artery with autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts. Number with each point indicates number of patent grafts observed for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, 104-114DOI: (10.1016/0741-5214(86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 2 Cumulative life-table primary patency rates for all randomized autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) bypass performed to popliteal artery (A), above-knee; (B), below-knee. Number with each point indicates number of patent grafts observed for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, 104-114DOI: (10.1016/0741-5214(86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 3 Cumulative life-table limb salvage rates for all patients with randomized autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts to popliteal artery. All operations represented here were performed to control critical ischemia. Number with each point indicates number of operated limbs observed to be intact for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, 104-114DOI: (10.1016/0741-5214(86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 4 Cumulative life-table primary patency rates for all randomized bypasses to infrapopliteal arteries with autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts. Number with each point indicates number of grafts observed to be patent for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, 104-114DOI: (10.1016/0741-5214(86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 5 Cumulative life-table limb salvage rates for patients with randomized autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts to infrapopliteal arteries. All operations represented here were performed to control critical ischemia. Number with each point indicates number of operated limbs observed to be intact for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, 104-114DOI: (10.1016/0741-5214(86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Fig. 6 Cumulative life-table primary patency rates for all randomized and obligatory polytetrafluoroethylene (PTFE) bypasses to popliteal artery. Number with each point represents number of patent grafts observed for that length of time. Standard error of each point is shown. Journal of Vascular Surgery 1986 3, 104-114DOI: (10.1016/0741-5214(86)90073-X) Copyright © 1986 Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions